These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 2129269)
1. Non-lytic antibodies in H-2-controlled resistance to acute infection with Trypanosoma cruzi. Juri MA; Ferreira A; Ramos A; Hoecker G Braz J Med Biol Res; 1990; 23(8):685-95. PubMed ID: 2129269 [TBL] [Abstract][Full Text] [Related]
2. Host genetics and resistance to acute Trypanosoma cruzi infection in mice. I. Antibody isotype profiles. Powell MR; Wassom DL Parasite Immunol; 1993 Apr; 15(4):215-21. PubMed ID: 8506117 [TBL] [Abstract][Full Text] [Related]
3. The effect of reinoculation with trypomastigotes on the level of protective antibodies in mice chronically infected with T. cruzi. Pereira ME; Krettli AU Braz J Med Biol Res; 1990; 23(3-4):283-92. PubMed ID: 2128821 [TBL] [Abstract][Full Text] [Related]
4. Lack of cross-reactivity of lytic antibodies with bloodstream forms of Trypanosoma cruzi zymodemes generated in a mouse experimental model. Wallace A; Sanchez G; Venegas J; Solari A Exp Parasitol; 1995 Mar; 80(2):176-85. PubMed ID: 7895829 [TBL] [Abstract][Full Text] [Related]
5. Non-antibody-mediated control of parasitemia in acute experimental Chagas' disease. Trischmann TM J Immunol; 1983 Apr; 130(4):1953-7. PubMed ID: 6403614 [TBL] [Abstract][Full Text] [Related]
6. Trypanosoma cruzi in the opossum Didelphis marsupialis: parasitological and serological follow-up of the acute infection. Jansen AM; Leon L; Machado GM; da Silva MH; Souza-Leão SM; Deane MP Exp Parasitol; 1991 Oct; 73(3):249-59. PubMed ID: 1915740 [TBL] [Abstract][Full Text] [Related]
7. Protective immunity against trypanosoma cruzi infection in a highly susceptible mouse strain after vaccination with genes encoding the amastigote surface protein-2 and trans-sialidase. Vasconcelos JR; Hiyane MI; Marinho CR; Claser C; Machado AM; Gazzinelli RT; Bruña-Romero O; Alvarez JM; Boscardin SB; Rodrigues MM Hum Gene Ther; 2004 Sep; 15(9):878-86. PubMed ID: 15353042 [TBL] [Abstract][Full Text] [Related]
8. Genetic control of responses to Trypanosoma cruzi in mice: multiple genes influencing parasitemia and survival. Wrightsman R; Krassner S; Watson J Infect Immun; 1982 May; 36(2):637-44. PubMed ID: 6806192 [TBL] [Abstract][Full Text] [Related]
9. Role of the H-2s haplotype in survival of mice after infection with Trypanosoma cruzi. Wrightsman RA; Krassner SM; Watson JD; Manning JE Infect Immun; 1984 May; 44(2):351-4. PubMed ID: 6425221 [TBL] [Abstract][Full Text] [Related]
10. Use of Tc-rCRP as a target for lytic antibody titration after experimental Trypanosoma cruzi infection. Marques T; Silva GC; Henrique Paiva PM; Nascentes GAN; Ramirez LE; Norris K; Meira WSF Exp Parasitol; 2018 Jan; 184():103-108. PubMed ID: 29246832 [TBL] [Abstract][Full Text] [Related]
11. Genetics of resistance to the African trypanosomes. VI. Heredity of resistance and variable surface glycoprotein-specific immune responses. De Gee AL; Levine RF; Mansfield JM J Immunol; 1988 Jan; 140(1):283-8. PubMed ID: 3121739 [TBL] [Abstract][Full Text] [Related]
12. Role of membrane-bound IgM in Trypanosoma cruzi evasion from immune clearance. Garcia IE; Lima MR; Marinho CR; Kipnis TL; Furtado GC; Alvarez JM J Parasitol; 1997 Apr; 83(2):230-3. PubMed ID: 9105302 [TBL] [Abstract][Full Text] [Related]
14. Relationship between long-term resistance to Trypanosoma cruzi and latent infection, examined by antibody production and polymerase chain reaction in mice. Basombrío MA; Segura MA; Nasser JR J Parasitol; 2002 Dec; 88(6):1107-12. PubMed ID: 12537102 [TBL] [Abstract][Full Text] [Related]
15. Comparative studies on epimastigote and metacyclic stages of Trypanosoma cruzi. II. Selective lysis by rodent sera. Chao D; Hsu YP; Chan CH; Chen YA Int J Zoonoses; 1985 Dec; 12(4):323-30. PubMed ID: 3939135 [TBL] [Abstract][Full Text] [Related]
16. Strain-specific protective immunity following vaccination against experimental Trypanosoma cruzi infection. Haolla FA; Claser C; de Alencar BC; Tzelepis F; de Vasconcelos JR; de Oliveira G; Silvério JC; Machado AV; Lannes-Vieira J; Bruna-Romero O; Gazzinelli RT; dos Santos RR; Soares MB; Rodrigues MM Vaccine; 2009 Sep; 27(41):5644-53. PubMed ID: 19635607 [TBL] [Abstract][Full Text] [Related]
17. Trypanosoma cruzi: serum antibody reactivity to the parasite antigens in susceptible and resistant mice. de Gaspari EN; Umezawa ES; Zingales B; Stolf AM; Colli W; Abrahamsohn IA Mem Inst Oswaldo Cruz; 1990; 85(3):261-70. PubMed ID: 2134701 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease. Bontempi IA; Vicco MH; Cabrera G; Villar SR; González FB; Roggero EA; Ameloot P; Callewaert N; Pérez AR; Marcipar IS Vaccine; 2015 Mar; 33(10):1274-83. PubMed ID: 25625671 [TBL] [Abstract][Full Text] [Related]
19. Trypanosoma cruzi: H2 complex and genetic background influence on the humoral immune response against epimastigotes. Aguillón JC; Hermosilla T; Molina MC; Morello A; Repetto Y; Orn A; Ferreira A Int J Parasitol; 2000 Aug; 30(9):981-4. PubMed ID: 10980286 [TBL] [Abstract][Full Text] [Related]